Changing outcomes for people with gastro-intestinal cancer
Every day, many Australians are affected by gastro-intestinal (GI) cancers, including cancers of the liver, pancreas, bowel, oesophagus, stomach, gallbladder, rectum and anus. GI Cancer Trials, formerly AGITG and the GI Cancer Institute, is committed to building a better future for people with GI cancer by delivering clinical trials that lead to better treatments, improved quality of life and longer survival. Since 1991, the organisation has developed and led more than 90 research studies, invested more than $120 million in GI Cancer Trials-led research, and given more than 10,000 people access to new treatment options through trials across Australia, Aotearoa New Zealand and international sites. Its multidisciplinary membership network includes more than 2,000 clinicians, researchers, nurses, allied health professionals, trial coordinators and community advocates, working together to transform outcomes for people with GI cancer. The organisation also raises awareness and funds to support new research and expand access to promising treatments.